What is it about?
This study describes the results of a clinical trial that evaluated the use of endoscopically delivered stromal vascular fraction from autologous adipose tissue (tSVFem) to treat gastrointestinal defects that were unresponsive to traditional endoscopic treatments. This study included 30 patients with esophageal and rectal defects. The preliminary results of this ongoing clinical trial (ClinicalTrials.gov number: NCT04670276) suggest that endoscopic injection of autologous tSVFem may treat complex esophageal and rectal defects.
Featured Image
Photo by National Cancer Institute on Unsplash
Read the Original
This page is a summary of: Regenerative endoscopy for the treatment of difficult gastrointestinal defects: results from a pilot trial, Endoscopy, July 2025, Thieme Publishing Group,
DOI: 10.1055/a-2665-1777.
You can read the full text:
Contributors
The following have contributed to this page
